An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
The expansion positions Cambrex with the largest and most advanced API facility in the United States
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
BioFluidica LiquidScan harnesses the power of microfluidics
The new facility is scheduled to start operation in the first half of 2024
Subscribe To Our Newsletter & Stay Updated
